Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2012

View Archived Issues

Novel therapeutic target for multiple sclerosis identified

Novel immunocytokine for rheumatoid arthritis shows promise in early-stage clinical trial

Universities team up to unveil new biomarker predicting TTR in colon cancer

Researchers at Leo Pharma synthesize novel CaSR agonists

Merck KGaA prepares novel protein kinase inhibitors

Spanish scientists develop new agents for neurodegenerative diseases

Alnylam product receives orphan drug status

Roche and Seaside Therapeutics to collaborate on treatments for neurodevelopmental disorders

New potassium channel blockers designed at Pierre Fabre

Japanese group patents novel DCP-LA enantiomers

Pharmacokinetics of pure icaritin investigated in rats

Janssen Pharmaceutica presents new matrix metalloproteinase inhibitors

Sirona Biochem reports findings on SGLT inhibitor in primates

FDA grants orphan drug status to new therapy for AML

RGN-259 improves severe dry eye in phase II trial

Biovest to seek approval for personalized NHL vaccine

NovaRx completes enrollment in pivotal Lucanix trial

Dosing begins in phase III MuDelta studies

Data monitoring committee recommends continued enrollment in Reolysin trial

FDA advisory committee votes on carfilzomib NDA

Biopump gets orphan drug status for hepatitis D

Pozen receives FDA response regarding PA-32540 bioequivalence study

Tetra Discovery Partners receives award from NIH

Medigene to advance optimized formulation of RhuDex

Otsuka and UCB Japan seek new approvals for antiepileptic drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...